We are live on ! Find out more
GIM

Granahan Investment Management Portfolio holdings

AUM $2.07B
1-Year Est. Return 56.45%
This Fund
S&P 500
This Quarter Est. Return
+7.8%
1 Year Est. Return
+56.45%
3 Year Est. Return
+154.74%
5 Year Est. Return
+144.99%
10 Year Est. Return
+2,522.93%
AUM
$2.91B
AUM Growth
-$322M
Cap. Flow
-$466M
Cap. Flow %
-16.01%
Top 10 Hldgs %
16.3%
Holding
266
New
11
Increased
65
Reduced
149
Closed
26

Sector Composition

Rank Sector Weight
1 Technology 33.61%
2 Healthcare 20.94%
3 Industrials 10.75%
4 Financials 6.48%
5 Consumer Discretionary 6.16%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
PFPT
126
DELISTED
Proofpoint, Inc.
PFPT
$7.14M 0.25%
109,845
-66,950
-38% -$4.49M
HIVE
127
DELISTED
Aerohive Networks
HIVE
$7.02M 0.24%
1,373,474
+80,689
+6% +$494K
LNKD
128
DELISTED
LinkedIn Corporation
LNKD
$6.99M 0.24%
31,062
BFH icon
129
Bread Financial
BFH
$4.38B
$6.98M 0.24%
31,638
PCRX icon
130
Pacira BioSciences
PCRX
$997M
$6.96M 0.24%
90,700
-91,100
-50% -$5.16M
SODA
131
DELISTED
SodaStream International Ltd
SODA
$6.93M 0.24%
425,186
-65,760
-13% -$1.01M
PVTB
132
DELISTED
PrivateBancorp Inc
PVTB
$6.88M 0.24%
+167,700
New +$7.03M
BGC icon
133
BGC Group
BGC
$4.89B
$6.87M 0.24%
+1,088,967
New +$6.27M
PRLB icon
134
Protolabs
PRLB
$2.13B
$6.82M 0.23%
107,000
+9,200
+9% +$593K
CGNX icon
135
Cognex
CGNX
$11.3B
$6.8M 0.23%
402,568
-633,064
-61% -$11.3M
OSIS icon
136
OSI Systems
OSIS
$3.89B
$6.73M 0.23%
75,949
-18,750
-20% -$1.64M
DSGR icon
137
Distribution Solutions Group
DSGR
$1.61B
$6.72M 0.23%
575,888
+320,526
+126% +$4.21M
ELOS
138
DELISTED
Syneron Medical Ltd
ELOS
$6.43M 0.22%
834,324
-235,931
-22% -$1.8M
LJPC
139
DELISTED
La Jolla Pharmaceutical Company
LJPC
$6.42M 0.22%
237,889
+25,541
+12% +$696K
PPBI
140
DELISTED
Pacific Premier Bancorp
PPBI
$6.28M 0.22%
295,300
+62,700
+27% +$1.38M
ENZ
141
DELISTED
Enzo Biochem, Inc.
ENZ
$6.27M 0.22%
1,393,962
+798,210
+134% +$3.37M
TIVO
142
DELISTED
TIVO INC
TIVO
$6.25M 0.21%
723,783
-274,149
-27% -$2.47M
PRTK
143
DELISTED
Paratek Pharmaceuticals, Inc.
PRTK
$6.24M 0.21%
329,019
-11,269
-3% -$215K
MDSO
144
DELISTED
Medidata Solutions, Inc.
MDSO
$6.22M 0.21%
126,244
-47,600
-27% -$2.09M
ALLT icon
145
Allot
ALLT
$383M
$6.19M 0.21%
1,062,984
-87,716
-8% -$484K
IPHI
146
DELISTED
INPHI CORPORATION
IPHI
$6.13M 0.21%
226,851
-344,800
-60% -$9.86M
OPWR
147
DELISTED
OPOWER INC COM STK (DE)
OPWR
$5.87M 0.2%
+556,069
New +$5.32M
TLPH icon
148
Talphera
TLPH
$74.2M
$5.84M 0.2%
75,807
-11,473
-13% -$984K
INST
149
DELISTED
Instructure, Inc.
INST
$5.78M 0.2%
+277,517
New +$5.41M
KNGT
150
DELISTED
KNIGHT TRANSPORTATION INC
KNGT
$5.76M 0.2%
237,580

Similar funds

Granahan Investment Management's Q4 2015 Portfolio in Review

As of Q4 2015, Granahan Investment Management held 266 positions worth $2.91B, down 10% from $3.23B the previous quarter. Its ten largest holdings account for 16% of the portfolio.

Granahan Investment Management withdrew a net $466M in Q4 2015, closing 26 positions and reducing 149 holdings. Its most notable exit was iShares Russell 2000 Growth ETF, an estimated $33.5M position sold in full.

By sector, the portfolio is most concentrated in Technology at 34% of assets, up from 33% a quarter earlier, followed by Healthcare and Industrials.

Against the trend, Granahan Investment Management opened a new position in Ionis Pharmaceuticals worth $13.1M.

  • Granahan Investment Management's largest Q4 2015 buy was Ionis Pharmaceuticals: 212,000 shares worth $13.1M.
  • Granahan Investment Management added most to Abiomed Inc in Q4 2015, an estimated $18M increase.
  • Granahan Investment Management's biggest Q4 2015 reduction was Crocs, cutting an estimated $20.8M.
  • Granahan Investment Management fully exited iShares Russell 2000 Growth ETF in Q4 2015, selling an estimated $33.5M.
  • Granahan Investment Management's ten largest holdings make up 16% of its $2.91B portfolio in Q4 2015.
  • Granahan Investment Management opened 11 new positions and closed 26 in Q4 2015.
  • Granahan Investment Management's portfolio value fell 10% quarter-over-quarter to $2.91B.

Based on Granahan Investment Management's 13F filing for Q4 2015, filed 12 Feb 2016.